相关实验视频
Updated: Sep 11, 2025

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3.4K
在2型糖尿病中重新使用尼塔佐胺:一项随机对照试验
Eman M Ghonaim1, Osama M Ibrahim2, Sahar K Hegazy2
1Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt. eman.ghonim@pharm.tanta.edu.eg.
Endocrine
|August 15, 2025
概括
尼塔佐化物 (NTZ) 可能降低2型糖尿病患者的炎症和氧化应激. 然而,这项研究发现,当NTZ添加到甲胺-维尔达格利普丁时,血糖控制没有显著改善.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 临床前研究表明,尼塔佐胺 (NTZ) 作为PPAR-γ激动剂,表明对2型糖尿病的潜在益处.
- 2型糖尿病与炎症和氧化应激增加有关.
研究的目的:
- 评估NTZ的耐受性和初步效果,作为2型糖尿病患者对甲胺-维尔达格利普丁的补充疗法.
- 评估NTZ对血糖控制和关键炎症生物标志物的影响.
主要方法:
- 一项试点试验涉及88名2型糖尿病患者,他们接受了甲胺-维尔达格利普丁治疗.
- 患者被随机分配到对照组和NTZ组 (每天两次500毫克) 三个月.
- 主要结局包括HbA1c和禁食血糖;次要结局涉及IL-6,HMGB-1,阿斯素和MDA等炎症标志物.
主要成果:
- 与对照组相比,NTZ显著降低了IL-6,HMGB-1,阿斯素和MDA的水平.
- 在NTZ组显示IL-6和HMGB-1的降低,而这些标志物在对照组增加.
- 两组之间没有观察到HbA1c,禁食血糖或禁食胰岛素的显著差异.
结论:
- 尼塔佐胺可能有助于缓解2型糖尿病的炎症和氧化应激.
- 当NTZ作为附加疗法使用时,它没有显示出血糖参数的显著改善.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
296
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
296
Oral Hypoglycemic Agents: Glinides
261
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
261
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374
Antihypertensive Drugs: Thiazide-Class Diuretics
874
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
874
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K

